A decrease in the abundance and biodiversity of intestinal bacteria within the Firmicutes phylum has been associated with inflammatory bowel disease (IBD). In particular, the anti-inflammatory bacterium Faecalibacterium prausnitzii, member of the Firmicutes phylum and one of the most abundant species in healthy human colon, is underrepresented in the microbiota of IBD patients. The aim of this study was to investigate the immunomodulatory properties of F. prausnitzii strain A2-165, the biofilm forming strain HTF-F and the extracellular polymeric matrix (EPM) isolated from strain HTF-F. For this purpose, the immunomodulatory properties of the F. prausnitzii strains and the EPM were studied in vitro using human monocyte-derived dendritic cells. Then, the capacity of the F. prausnitzii strains and the EPM of HTF-F to suppress inflammation was assessed in vivo in the mouse dextran sodium sulphate (DSS) colitis model. The F. prausnitzii strains and the EPM had anti-inflammatory effects on the clinical parameters measured in the DSS model but with different efficacy. The immunomodulatory effects of the EPM were mediated through the TLR2-dependent modulation of IL-12 and IL-10 cytokine production in antigen presenting cells, suggesting that it contributes to the anti-inflammatory potency of F. prausnitzii HTF-F. The results show that F. prausnitzii HTF-F and its EPM may have a therapeutic use in IBD.

Department of Cell Biology section Membrane Cell Biology University Medical Center Groningen Groningen The Netherlands

Department of Pediatrics Division of Gastroenterology and Nutrition Erasmus Medical Center Sophia Children's Hospital Rotterdam The Netherlands

Host Microbe Interactomics Group Animal Science Department University of Wageningen Wageningen The Netherlands

Institute of Microbiology of the Academy of Sciences of the Czech Republic Prague Czech Republic

Microbial Ecology Group Rowett Institute of Nutrition and Health University of Aberdeen Aberdeen United Kingdom

See more in PubMed

Seksik P, Rigottier-Gois L, Gramet G, Sutren M, Pochart P, Marteau P, et al. Alterations of the dominant faecal bacterial groups in patients with Crohn's disease of the colon. Gut. 2003;52(2):237–42. Epub 2003/01/14. PubMed PMC

Macfarlane GT, Blackett KL, Nakayama T, Steed H, Macfarlane S. The gut microbiota in inflammatory bowel disease. Current pharmaceutical design. 2009;15(13):1528–36. Epub 2009/05/16. PubMed

Frank DN, St Amand AL, Feldman RA, Boedeker EC, Harpaz N, Pace NR. Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc Natl Acad Sci U S A. 2007;104(34):13780–5. Epub 2007/08/19. PubMed PMC

Walker AW, Ince J, Duncan SH, Webster LM, Holtrop G, Ze X, et al. Dominant and diet-responsive groups of bacteria within the human colonic microbiota. The ISME journal. 2011;5(2):220–30. Epub 2010/08/06. 10.1038/ismej.2010.118 PubMed DOI PMC

Sokol H, Seksik P, Furet JP, Firmesse O, Nion-Larmurier I, Beaugerie L, et al. Low counts of Faecalibacterium prausnitzii in colitis microbiota. Inflammatory bowel diseases. 2009;15(8):1183–9. Epub 2009/02/25. 10.1002/ibd.20903 PubMed DOI

Martin R, Chain F, Miquel S, Lu J, Gratadoux JJ, Sokol H, et al. The commensal bacterium Faecalibacterium prausnitzii is protective in DNBS-induced chronic moderate and severe colitis models. Inflammatory bowel diseases. 2014;20(3):417–30. Epub 2014/01/15. 10.1097/01.MIB.0000440815.76627.64 PubMed DOI

Sokol H, Pigneur B, Watterlot L, Lakhdari O, Bermudez-Humaran LG, Gratadoux JJ, et al. Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc Natl Acad Sci U S A. 2008;105(43):16731–6. Epub 2008/10/22. 10.1073/pnas.0804812105 PubMed DOI PMC

Mazmanian SK, Round JL, Kasper DL. A microbial symbiosis factor prevents intestinal inflammatory disease. Nature. 2008;453(7195):620–5. Epub 2008/05/30. 10.1038/nature07008 PubMed DOI

Round JL, Mazmanian SK. Inducible Foxp3+ regulatory T-cell development by a commensal bacterium of the intestinal microbiota. Proc Natl Acad Sci U S A. 2010;107(27):12204–9. Epub 2010/06/23. 10.1073/pnas.0909122107 PubMed DOI PMC

Fanning S, Hall LJ, Cronin M, Zomer A, MacSharry J, Goulding D, et al. Bifidobacterial surface-exopolysaccharide facilitates commensal-host interaction through immune modulation and pathogen protection. Proc Natl Acad Sci U S A. 2011;109(6):2108–13. PubMed PMC

Barcenilla A, Pryde SE, Martin J, Duncan SH, Stewart CS, Henderson C, et al. Phylogenetic Relationships of Butyrate-Producing Bacteria from the Human Gut. Applied and environmental microbiology. 2000. PubMed PMC

Duncan SH. Growth requirements and fermentation products of Fusobacterium prausnitzii, and a proposal to reclassify it as Faecalibacterium prausnitzii gen. nov., comb. nov. International Journal of Systematic and Evolutionary Microbiology. 2002;52(6):2141–6. PubMed

Lopez-Siles M, Khan TM, Duncan SH, Harmsen HJ, Garcia-Gil LJ, Flint HJ. Cultured representatives of two major phylogroups of human colonic Faecalibacterium prausnitzii can utilize pectin, uronic acids, and host-derived substrates for growth. Applied and environmental microbiology. 2012;78(2):420–8. Epub 2011/11/22. 10.1128/AEM.06858-11 PubMed DOI PMC

Schabussova I, Hufnagl K, Tang ML, Hoflehner E, Wagner A, Loupal G, et al. Perinatal maternal administration of Lactobacillus paracasei NCC 2461 prevents allergic inflammation in a mouse model of birch pollen allergy. PLoS One. 2012;7(7):e40271 Epub 2012/07/14. 10.1371/journal.pone.0040271 PubMed DOI PMC

Ricciardi A, Parente E., Aquino M., Clementi F. Use of desalting gel for the rapid separation of simple sugars from exopolysaccharides produced by lactic acid bacteria. Biotechnol Tech. 1998;12:649–52.

Rozen S, Skaletsky H. Primer3 on the WWW for general users and for biologist programmers. Methods Mol Biol. 2000;132:365–86. Epub 1999/11/05. PubMed

Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic acids research. 2001;29(9):e45 Epub 2001/05/09. PubMed PMC

Lutz MB, Kukutsch N, Ogilvie AL, Rossner S, Koch F, Romani N, et al. An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. Journal of immunological methods. 1999;223(1):77–92. Epub 1999/02/26. PubMed

Cooper HS, Murthy SN, Shah RS, Sedergran DJ. Clinicopathologic study of dextran sulfate sodium experimental murine colitis. Laboratory investigation; a journal of technical methods and pathology. 1993;69(2):238–49. Epub 1993/08/01. PubMed

Flemming HC, Wingender J. The biofilm matrix. Nat Rev Microbiol. 2010;8(9):623–33. Epub 2010/08/03. 10.1038/nrmicro2415 PubMed DOI

Meijerink M, Ferrando ML, Lammers G, Taverne N, Smith HE, Wells JM. Immunomodulatory effects of Streptococcus suis capsule type on human dendritic cell responses, phagocytosis and intracellular survival. PLoS One. 2012;7(4):e35849 Epub 2012/05/05. 10.1371/journal.pone.0035849 PubMed DOI PMC

Hamer HM, Jonkers D, Venema K, Vanhoutvin S, Troost FJ, Brummer RJ. Review article: the role of butyrate on colonic function. Alimentary pharmacology & therapeutics. 2008;27(2):104–19. Epub 2007/11/02. PubMed

Hamer HM, Jonkers DM, Vanhoutvin SA, Troost FJ, Rijkers G, de Bruine A, et al. Effect of butyrate enemas on inflammation and antioxidant status in the colonic mucosa of patients with ulcerative colitis in remission. Clin Nutr. 2010;29(6):738–44. Epub 2010/05/18. 10.1016/j.clnu.2010.04.002 PubMed DOI

Geuking MB, Cahenzli J, Lawson MA, Ng DC, Slack E, Hapfelmeier S, et al. Intestinal bacterial colonization induces mutualistic regulatory T cell responses. Immunity. 2011;34(5):794–806. Epub 2011/05/21. 10.1016/j.immuni.2011.03.021 PubMed DOI

Veenbergen S, Samsom JN. Maintenance of small intestinal and colonic tolerance by IL-10-producing regulatory T cell subsets. Curr Opin Immunol. 2012;24(3):269–76. Epub 2012/04/17. 10.1016/j.coi.2012.03.004 PubMed DOI

Murai M, Turovskaya O, Kim G, Madan R, Karp CL, Cheroutre H, et al. Interleukin 10 acts on regulatory T cells to maintain expression of the transcription factor Foxp3 and suppressive function in mice with colitis. Nat Immunol. 2009;10(11):1178–84. Epub 2009/09/29. 10.1038/ni.1791 PubMed DOI PMC

Manuzak J, Dillon S, Wilson C. Differential Interleukin-10 (IL-10) and IL-23 Production by Human Blood Monocytes and Dendritic Cells in Response to Commensal Enteric Bacteria. Clinical and vaccine immunology: CVI. 2012;19(8):1207–17. Epub 2012/06/15. 10.1128/CVI.00282-12 PubMed DOI PMC

Human gut bifidobacteria inhibit the growth of the opportunistic fungal pathogen Candida albicans